617 related articles for article (PubMed ID: 8604395)
41. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene.
Kyprianou N; Isaacs JT
Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838
[TBL] [Abstract][Full Text] [Related]
42. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity.
Gao AC; Lou W; Isaacs JT
Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237
[TBL] [Abstract][Full Text] [Related]
43. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
44. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
[TBL] [Abstract][Full Text] [Related]
45. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1].
Che GW; Zhou QH; Zhu W; Wang YP; Qin Y; Liu LX; Chen XH; Sun YL; Sun ZF
Ai Zheng; 2005 Mar; 24(3):278-84. PubMed ID: 15757527
[TBL] [Abstract][Full Text] [Related]
46. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer.
Singh LS; Berk M; Oates R; Zhao Z; Tan H; Jiang Y; Zhou A; Kirmani K; Steinmetz R; Lindner D; Xu Y
J Natl Cancer Inst; 2007 Sep; 99(17):1313-27. PubMed ID: 17728215
[TBL] [Abstract][Full Text] [Related]
47. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
48. Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells.
Liu N; Gao F; Han Z; Xu X; Underhill CB; Zhang L
Cancer Res; 2001 Jul; 61(13):5207-14. PubMed ID: 11431361
[TBL] [Abstract][Full Text] [Related]
49. Metastatic potential of cloned murine melanoma cells transfected with activated c-Ha-ras.
Price JE; Aukerman SL; Ananthaswamy HN; McIntyre BW; Schackert G; Schackert HK; Fidler IJ
Cancer Res; 1989 Aug; 49(15):4274-81. PubMed ID: 2663141
[TBL] [Abstract][Full Text] [Related]
50. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model.
Oates AJ; Barraclough R; Rudland PS
Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559
[TBL] [Abstract][Full Text] [Related]
51. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
[TBL] [Abstract][Full Text] [Related]
52. Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.
Taplin ME; Bubley GJ; Shuster TD; Frantz ME; Spooner AE; Ogata GK; Keer HN; Balk SP
N Engl J Med; 1995 May; 332(21):1393-8. PubMed ID: 7723794
[TBL] [Abstract][Full Text] [Related]
53. ErbB-4 may control behavior of prostate cancer cells and serve as a target for molecular therapy.
Ben-Yosef R; Starr A; Karaush V; Loew V; Lev-Ari S; Barnea I; Lidawi G; Shtabsky A; Greif Y; Yarden Y; Vexler A
Prostate; 2007 Jun; 67(8):871-80. PubMed ID: 17440944
[TBL] [Abstract][Full Text] [Related]
54. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
55. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
[TBL] [Abstract][Full Text] [Related]
56. Endothelin-1 production and decreased endothelin B receptor expression in advanced prostate cancer.
Nelson JB; Chan-Tack K; Hedican SP; Magnuson SR; Opgenorth TJ; Bova GS; Simons JW
Cancer Res; 1996 Feb; 56(4):663-8. PubMed ID: 8630991
[TBL] [Abstract][Full Text] [Related]
57. Detection of low level HER-2/neu gene amplification in prostate cancer by fluorescence in situ hybridization.
Liu HL; Gandour-Edwards R; Lara PN; de Vere White R; LaSalle JM
Cancer J; 2001; 7(5):395-403. PubMed ID: 11693898
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
Yu D; Hamada J; Zhang H; Nicolson GL; Hung MC
Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
[TBL] [Abstract][Full Text] [Related]
59. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene.
Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW
Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]